Skip to main content

Table 2 Costs of CHC treatment

From: Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6

Cost parameters Mean Standard error Distribution Ref.
Medication, laboratory and diagnostic tests costs
 Pegylated interferon alfa-2a + Ribavirin (per week) 3,150 630 Gamma [35]
 Pegylated interferon alfa-2b + Ribavirin (per week) 3,150 630 Gamma [35]
 Investigation and monitoring 16,277 3,255 Gamma [34]
Direct medical cost for complication treatment
 Costs of chronic HCV infection (per year) 65,640 19,723 Gamma [33]
 Costs of compensated cirrhosis (per year) 73,532 18,605 Gamma [33]
 Costs of decompensated cirrhosis (per year) 138,141 18,996 Gamma [33]
 Costs of hepatocellular carcinoma (per year) 168,899 11,601 Gamma [33]
Direct non-medical cost for complication treatment
 Costs of chronic HCV infection (per year) 4,303 430.3 Gamma [33, 34]
 Costs of compensated cirrhosis (per year) 4,216 421.6 Gamma [33, 34]
 Costs of decompensated cirrhosis (per year) 5,823 582.3 Gamma [33, 34]
 Costs of hepatocellular carcinoma (per year) 9,516 951.6 Gamma [33, 34]